| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 278, Issue 37, 34743-34746, September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute for Cancer Genetics, Department of Pathology, Columbia University, New York, New York 10032
The BRCA1 tumor suppressor forms a heterodimer with the BARD1 protein, and the resulting complex functions as an E3 ubiquitin ligase that catalyzes the synthesis of polyubiquitin chains. In theory, polyubiquitination can occur by isopeptide bond formation at any of the seven lysine residues of ubiquitin. The isopeptide linkage of a polyubiquitin chain is a particularly important determinant of its cellular function, such that K48-linked chains commonly target proteins for proteasomal degradation, while K63 chains serve non-proteolytic roles in various signaling pathways. To determine the isopeptide linkage formed by BRCA1/BARD1-dependent polyubiquitination, we purified a full-length heterodimeric complex and compared its linkage specificity with that of E6-AP, an E3 ligase known to induce proteolysis of its cellular substrates. Using a comprehensive mutation analysis, we found that E6-AP catalyzes the synthesis of K48-linked polyubiquitin chains. In contrast, however, the BRCA1/BARD1 heterodimer directs polymerization of ubiquitin primarily through an unconventional linkage involving lysine residue K6. Although heterologous substrates of BRCA1/BARD1 are not known, BRCA1 autoubiquitination occurs principally by conjugation with K6-linked polymers. The ability of BRCA1/BARD1 to form K6-linked polyubiquitin chains suggests that it may impart unique cellular properties to its natural enzymatic substrates.
Received for publication, June 6, 2003 , and in revised form, July 28, 2003.
* This work was supported by Grant CA97403 (Project 4) from the NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Inst. for Cancer Genetics,
Columbia University, 1150 St. Nicholas Ave., New York, NY 10032. E-mail:
rb670{at}columbia.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  X. H. Yang and L. Zou Launching a ubiquitination cascade at DNA breaks PNAS, December 26, 2007; 104(52): 20645 - 20646. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bish and M. P. Myers Werner Helicase-interacting Protein 1 Binds Polyubiquitin via Its Zinc Finger Domain J. Biol. Chem., August 10, 2007; 282(32): 23184 - 23193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Kim, K. P. Kim, F. Lledias, A. F. Kisselev, K. M. Scaglione, D. Skowyra, S. P. Gygi, and A. L. Goldberg Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages J. Biol. Chem., June 15, 2007; 282(24): 17375 - 17386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sobhian, G. Shao, D. R. Lilli, A. C. Culhane, L. A. Moreau, B. Xia, D. M. Livingston, and R. A. Greenberg RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites Science, May 25, 2007; 316(5828): 1198 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Horwitz, E. B. Affar, G. F. Heine, Y. Shi, and J. D. Parvin A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase PNAS, April 17, 2007; 104(16): 6614 - 6619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lu, A. Amleh, J. Sun, X. Jin, S. D. McCullough, R. Baer, D. Ren, R. Li, and Y. Hu Ubiquitination and Proteasome-Mediated Degradation of BRCA1 and BARD1 during Steroidogenesis in Human Ovarian Granulosa Cells Mol. Endocrinol., March 1, 2007; 21(3): 651 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wu, H. Nishikawa, R. Hayami, K. Sato, A. Honda, S. Aratani, T. Nakajima, M. Fukuda, and T. Ohta BRCA1 Ubiquitinates RPB8 in Response to DNA Damage Cancer Res., February 1, 2007; 67(3): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kee, W. Munoz, N. Lyon, and J. M. Huibregtse The Deubiquitinating Enzyme Ubp2 Modulates Rsp5-dependent Lys63-linked Polyubiquitin Conjugates in Saccharomyces cerevisiae J. Biol. Chem., December 1, 2006; 281(48): 36724 - 36731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yu, S. Fu, M. Lai, R. Baer, and J. Chen BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes & Dev., July 1, 2006; 20(13): 1721 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mani and E. P. Gelmann The Ubiquitin-Proteasome Pathway and Its Role in Cancer J. Clin. Oncol., July 20, 2005; 23(21): 4776 - 4789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Starita, A. A. Horwitz, M.-C. Keogh, C. Ishioka, J. D. Parvin, and N. Chiba BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II J. Biol. Chem., July 1, 2005; 280(26): 24498 - 24505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Kleiman, F. Wu-Baer, D. Fonseca, S. Kaneko, R. Baer, and J. L. Manley BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II Genes & Dev., May 15, 2005; 19(10): 1227 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pastushok, T. F. Moraes, M. J. Ellison, and W. Xiao A Single Mms2 "Key" Residue Insertion into a Ubc13 Pocket Determines the Interface Specificity of a Human Lys63 Ubiquitin Conjugation Complex J. Biol. Chem., May 6, 2005; 280(18): 17891 - 17900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hayami, K. Sato, W. Wu, T. Nishikawa, J. Hiroi, R. Ohtani-Kaneko, M. Fukuda, and T. Ohta Down-regulation of BRCA1-BARD1 Ubiquitin Ligase by CDK2 Cancer Res., January 1, 2005; 65(1): 6 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Frazier, D. Shakes, U. Hota, and L. Boyd Caenorhabditis elegans UBC-2 functions with the anaphase-promoting complex but also has other activities J. Cell Sci., October 15, 2004; 117(22): 5427 - 5435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Starita, Y. Machida, S. Sankaran, J. E. Elias, K. Griffin, B. P. Schlegel, S. P. Gygi, and J. D. Parvin BRCA1-Dependent Ubiquitination of {gamma}-Tubulin Regulates Centrosome Number Mol. Cell. Biol., October 1, 2004; 24(19): 8457 - 8466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang, and S. A. Aaronson BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage Mol. Cell. Biol., September 1, 2004; 24(17): 7444 - 7455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Choudhury, H. Xu, and R. Baer Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sato, R. Hayami, W. Wu, T. Nishikawa, H. Nishikawa, Y. Okuda, H. Ogata, M. Fukuda, and T. Ohta Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase J. Biol. Chem., July 23, 2004; 279(30): 30919 - 30922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Morris and E. Solomon BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair Hum. Mol. Genet., April 15, 2004; 13(8): 807 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nishikawa, S. Ooka, K. Sato, K. Arima, J. Okamoto, R. E. Klevit, M. Fukuda, and T. Ohta Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase J. Biol. Chem., February 6, 2004; 279(6): 3916 - 3924. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
